
Loading, please wait...

Loading, please wait...

The C-GALL randomized trial compared laparoscopic cholecystectomy with conservative management in adults with uncomplicated symptomatic gallstone disease. The study addressed a practical question faced frequently in general surgery: does every patient with uncomplicated symptomatic gallstones benefit from immediate operation? At 18 months, the trial did not find a significant difference in the prespecified measure of bodily pain between the two strategies. Importantly, however, many patients who initially chose conservative management eventually crossed over to surgery, showing that non-operative care does not necessarily eliminate the future need for cholecystectomy. For surgeons, the study supports more individualized decision-making rather than assuming that surgery is automatically required in every uncomplicated symptomatic case. Patient symptoms, impact on daily life, preferences, recurrence risk, access to follow-up and willingness to undergo later surgery all matter. C-GALL is particularly relevant to shared decision-making. Conservative management can be a reasonable option for selected patients, provided they receive clear information about the possibility of persistent or recurrent symptoms and subsequent surgery. The study also demonstrates why surgical policy should be based on patient-centred outcomes rather than operative feasibility alone. The practical message is to distinguish uncomplicated symptomatic disease from complicated gallstone presentations where urgent or definitive surgical management remains essential.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


The C-GALL randomized trial compared laparoscopic cholecystectomy with conservative management in adults with uncomplicated symptomatic gallstone disease. The study addressed a practical question faced frequently in general surgery: does every patient with uncomplicated symptomatic gallstones benefit from immediate operation? At 18 months, the trial did not find a significant difference in the prespecified measure of bodily pain between the two strategies. Importantly, however, many patients who initially chose conservative management eventually crossed over to surgery, showing that non-operative care does not necessarily eliminate the future need for cholecystectomy. For surgeons, the study supports more individualized decision-making rather than assuming that surgery is automatically required in every uncomplicated symptomatic case. Patient symptoms, impact on daily life, preferences, recurrence risk, access to follow-up and willingness to undergo later surgery all matter. C-GALL is particularly relevant to shared decision-making. Conservative management can be a reasonable option for selected patients, provided they receive clear information about the possibility of persistent or recurrent symptoms and subsequent surgery. The study also demonstrates why surgical policy should be based on patient-centred outcomes rather than operative feasibility alone. The practical message is to distinguish uncomplicated symptomatic disease from complicated gallstone presentations where urgent or definitive surgical management remains essential.
4 weeks back

Discover how catalytic nanozymes redefine autoimmune disease therapy by establishing a physiological redox set-point to restore immune tolerance without broad immunosuppression.
Last week

Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
3 weeks back

A landmark comparative study evaluates atrial electrophysiology across humans, swine, and rodents. By linking cellular recordings with transcriptomics and in silico modeling, researchers resolve cross-species gaps, explaining translational failures to advance targeted therapies for atrial arrhythmias.
3 weeks back

A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
last month

Researchers have developed an innovative ultrasound-responsive nano-contrast agent that co-delivers CIITA-siRNA and rapamycin directly to inflamed thyroid tissue, significantly reducing autoimmune injury and thyroid autoantibodies in preclinical models of Hashimoto thyroiditis.
3 weeks back